From the databaseWhat the row says.
Every entry follows the same shape: what is happening, the mechanism, and the recommendation.
Scope
Supplement × Prescription
Last verified
June 4, 2026
CautionEmerging evidence
What is happening. High-dose quercetin may inhibit CYP3A4 or transporters, potentially increasing tolterodine exposure in some patients.
Mechanism. Potential CYP3A4 and transporter inhibition.
Recommendation. Monitor dry mouth, constipation, urinary retention, blurred vision, palpitations, or dizziness after changes in quercetin use.
Stack Score
How it moves the number.
Effect on the composite score
If both Quercetin and Tolterodine are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.
SourcesSources, by evidence tier.
Every claim on this page is cited. PMIDs link straight to PubMed.
Reference material
1- 1U.S. National Library of Medicine. Tolterodine Tartrate Extended-Release Capsules US Prescribing Information. 2026.Needs sourceNo link